Why is Amerise BioScie falling/rising?

As of 15-Sep, Amerise Biosciences Ltd is currently priced at 0.70, reflecting a decrease of 0.02 or 2.78%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 6.67% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. In terms of returns, the stock has shown a year-to-date decline of 42.15%, while it has underperformed the sector by 3.25% today. There is a slight increase in investor participation, with a delivery volume of 45.02k on September 12, which is up by 0.56% compared to the 5-day average, suggesting some interest despite the overall negative performance.
Broader market context indicates that the stock's performance has been notably weaker than the benchmark, with a 1-month return of -1.41% compared to the Sensex's gain of 1.47%. Over the past week, the stock has remained flat at 0.00%, while the Sensex has increased by 1.24%. The significant underperformance over various time frames, including a 3-year decline of 32.04% against a 36.46% rise in the benchmark, highlights the challenges faced by Amerise Biosciences Ltd in the current market environment.